EUVIMEDEUVIMED entdecken
Crossref

Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects

Anil Malleshappa, Krutika Katageri

International Journal of Drug Delivery Technology · 28.07.2026 · 16 (70s)

DOI: 10.25258/ijddt.16.70s.29 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 28.07.2026. Verfasst von Anil Malleshappa und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Malleshappa, A., & Katageri, K. (2026). Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects. International Journal of Drug Delivery Technology, 16(70s). https://doi.org/10.25258/ijddt.16.70s.29

Vancouver

Malleshappa A, Katageri K. Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects. International Journal of Drug Delivery Technology. 2026;16(70s). doi:10.25258/ijddt.16.70s.29

BibTeX
@article{Malleshappa2026,
  author = {Malleshappa, Anil and Katageri, Krutika},
  title = {Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {70s},
  doi = {10.25258/ijddt.16.70s.29}
}
Kostenlos starten →